抑制性抗逆转录病毒治疗中完整HIV-1前病毒DNA的选择性衰减
该研究长期纵向随访40例接受抗逆转录病毒治疗(ART)者,分别定量完整与缺陷前病毒。完整前病毒水平随时间显著下降(中位半衰期7.1年,95%CI 3.9-18),缺陷前病毒未下降;总HIV-1 DNA中位半衰期41.6年(95%CI 13.6-75)。完整前病毒比例从约10%降至约5%。
要点
- 完整前病毒在抑制性ART下选择性衰减,中位半衰期7.1年。
- 缺陷前病毒水平不随时间下降,总HIV-1 DNA衰减极慢。
- 完整前病毒水平与总HIV-1 DNA及残余血浆病毒血症相关。
核心结论
- 含完整、具复制能力前病毒的细胞在抑制性ART期间被选择性丢失。
研究设计与样本
- 对40例长期ART者从ART启动后中位7.1年至12年进行纵向随访,分别定量完整与缺陷前病毒、残余血浆病毒血症及炎症和激活标志物。
主要发现
- 完整前病毒水平随时间显著下降,中位半衰期7.1年(95%CI 3.9-18)。
- 缺陷前病毒水平未见下降。
- 总HIV-1 DNA中位半衰期为41.6年(95%CI 13.6-75)。
- 全部前病毒中完整前病毒比例从首次ART时点约10%降至最后时点约5%。
- 完整前病毒水平与总HIV-1 DNA及残余血浆病毒血症相关,但与炎症或免疫激活无关联证据。
临床怎么用
- 监测完整前病毒水平可能有助于评估HIV-1储存库变化,但尚需进一步研究指导临床决策。
局限性
- 样本量40例,随访时间有限,未明确完整前病毒选择性丢失的具体机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: HIV-1 proviruses persist in people on antiretroviral therapy (ART) but most are defective and do not constitute a replication-competent reservoir. The decay of infected cells carrying intact compared with defective HIV-1 proviruses has not been well defined in people on ART. METHODS: We separately quantified intact and defective proviruses, residual plasma viremia, and markers of inflammation and activation in people on long-term ART. RESULTS: Among 40 participants tested longitudinally from a median of 7.1 years to 12 years after ART initiation, intact provirus levels declined significantly over time (median half-life, 7.1 years; 95% confidence interval [CI], 3.9-18), whereas defective provirus levels did not decrease. The median half-life of total HIV-1 DNA was 41.6 years (95% CI, 13.6-75). The proportion of all proviruses that were intact diminished over time on ART, from about 10% at the first on-ART time point to about 5% at the last. Intact provirus levels on ART correlated with total HIV-1 DNA and residual plasma viremia, but there was no evidence for associations between intact provirus levels and inflammation or immune activation. CONCLUSIONS: Cells containing intact, replication-competent proviruses are selectively lost during suppressive ART. Defining the mechanisms involved should inform strategies to accelerate HIV-1 reservoir depletion.
引用
- Gandhi RT, Cyktor JC, Bosch RJ, et al. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy. J Infect Dis. 2021. PMID: 32823274. doi:10.1093/infdis/jiaa532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。